Aleix Fabregat

Grup de recerca

Recerca translacional en noves estratègies terapèutiques i diagnòstiques en malalties hepàtiques Post-doctoral researcher (R2A)

afabregat@clinic.cat 0000-0002-4855-0306

Segueix-lo/a a:

El perfil de ResearchGate de Aleix Borja . Aquest enllaç s'obre en una nova pestanya.
El perfil de Linkedin de Aleix Borja . Aquest enllaç s'obre en una nova pestanya.

Publicacions destacades

Can AI Outperform Human Aspirants? Evaluating 3 ChatGPT Models on the Spanish FIR and BIR Specialized Health Examinations.

Autors:
Verdú G; Rayo AC; Fabregat-Bolufer AB;

Referència: Journal Of Applied Laboratory Medicine 2025.
Data-Driven Reference Intervals in Modern Laboratory Medicine: New Web Tools to Refine Vitamin D Status

Autors:
Barragán Muñoz Á; Fabregat-Bolufer AB;

Referència: Journal Of Applied Laboratory Medicine 2025.
Comparison of two automated immunoassays for quantifying ProGRP, SCC and HE4 in serum: impact on diagnostic accuracy

Autors:
de Medrano, Jaime I Sainz; Laguna, Javier; Julian, Judit; Filella, Xavier; Fabregat, Aleix;

Luquin, Maria; Hurtado, Harol H; Humanes, Alba Garcia; Morales-Ruiz, Manuel; Fernandez-Galan, Esther.

Referència: Scandinavian Journal Of Clinical & Laboratory Investigation 2025.
Redefining vitamin D status: Establishing population-based indirect reference intervals through big data analysis

Autors:
Fabregat-Bolufer, Aleix B; Escola-Rodriguez, Alba; Bedini-Chesa, Jose Luis; Casals, Gregori; Morales-Ruiz, Manuel;

Filella, Xavier.

Referència: Clinica Chimica Acta 2025.
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia

Autors:
Pineyroa, Juan A; Lopez-Oreja, Irene; Nadeu, Ferran; Martinez-Farran, Ares; Arostegui, Juan Ignacio;

(...)

Bea, Silvia; Campo, Elias; Delgado, Julio; Colomer, Dolors; Mozas, Pablo.

Referència: Cells 2024.
Diagnosis of cocaine-induced midline destructive lesions

Autors:
Escola-Rodriguez, Alba; Parra-Robert, Marina; Carrasco-Gomez, Daniel; Escartin-Diez, Teresa; Fabregat-Bolufer, Aleix B;

Referència: Clinical Toxicology 2023.
Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain) GONOvig project

Autors:
Aleix Borja Fabregat Bolufer; Felipe Bueno Ferrando; David Navarro Ortega; Javier Colomina Rodríguez;

Referència: 2023.
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact

Autors:
Mozas, Pablo; Pineyroa, Juan A; Nadeu, Ferran; Magnano, Laura; Rivero, Andrea;

(...)

Arostegui, Juan Ignacio; Aymerich, Marta; Lopez-Guillermo, Armando; Campo, Elias; Delgado, Julio.

Referència: Haematologica 2021.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma

Autors:
Mozas, Pablo; Rivero, Andrea; Rivas-Delgado, Alfredo; Fabregat, Aleix; Pineyroa, Juan A;

(...)

Campo, Elias; Arostegui, Juan I; Blade, Joan; Magnano, Laura; Lopez-Guillermo, Armando.

Referència: British Journal Of Haematology 2021.
Hb A1c Determination by Capillary Electrophoresis is an Efficient Method for Detecting -Thalassemias and Hemoglobin Variants

Autors:
Orts, Juan A; Zuniga, Angel; Bello, Yanis; Fabregat, Aleix B; Vicente, Ana I;

Referència: Hemoglobin 2016.

Projectes destacats

Treatment of metabolic liver disease using multicatalytic gold nanozymes

Codi: PI24/00688; G59319681

Durada: 11/07/2024

Web: https://investigacion.us.es/docs/convocatorias/2024/1682/pi24_resolucion_provisional_de_concesion.pdf
Proyecto GONOvig

Finançador: Hospital de la Ribera

Codi: PIBR17/04

Durada: 01/03/2017

Web: https://roderic.uv.es/items/7c1f2c1f-7d54-4e9d-b5d2-dfcdd26c92c3

Aleix Fabregat

Grup de recerca

Publicacions destacades

Projectes destacats

Treatment of metabolic liver disease using multicatalytic gold nanozymes

Proyecto GONOvig

Subscriu-te a la Newsletter del Clínic